As with its predecessor, the new drug candidate, Jun13296, targets a different viral protein than Paxlovid does and works ...

Lexicon Pharmaceuticals, headquartered in The Woodlands, announced it will exclusively license its drug LX9851 to the maker ...

Piper Sandler analyst Allison Bratzel maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) today and set a price target of $115.00. The company’s shares closed last ...

19:50 EDT Hepion Pharmaceuticals (HEPA) trading halted, news pending Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed competitor analyses. Published ...

VICTORIA, BC, March 20, 2025 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology ...

Blog posts represent the views of CFR fellows and staff and not those of CFR, which takes no institutional positions. Most of the major U.S. pharmaceutical companies (AbbVie, Amgen, Bristol Myers ...

The best logo maker is an essential design tool for anyone looking to differentiate their brand online. My round-up here offers apps ideal for designers and non-designers who need to help their ...

Biopharmaceutical company Vivasun Pharmaceutical is strong in early trading on the 5th. The increased buying interest is interpreted as news that their domestic No. 38 new drug, Anafraju, a non ...

It offers a sustainable - and affordable – alternative to synthesizing important peptide-based pharmaceuticals, thanks to a plant-based production system known as biopharming.